Details for New Drug Application (NDA): 072131
✉ Email this page to a colleague
NDA 072131 describes MAPROTILINE HYDROCHLORIDE, which is a drug marketed by Am Therap, Heritage Pharma, Rising, and Watson Labs, and is included in ten NDAs. Additional details are available on the MAPROTILINE HYDROCHLORIDE profile page.
The generic ingredient in MAPROTILINE HYDROCHLORIDE is maprotiline hydrochloride. There are three drug master file entries for this compound. Additional details are available on the maprotiline hydrochloride profile page.
The generic ingredient in MAPROTILINE HYDROCHLORIDE is maprotiline hydrochloride. There are three drug master file entries for this compound. Additional details are available on the maprotiline hydrochloride profile page.
Summary for 072131
| Tradename: | MAPROTILINE HYDROCHLORIDE |
| Applicant: | Am Therap |
| Ingredient: | maprotiline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072131
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 75MG | ||||
| Approval Date: | Jan 14, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
